BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10440129)

  • 1. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
    Buteau J; Roduit R; Susini S; Prentki M
    Diabetologia; 1999 Jul; 42(7):856-64. PubMed ID: 10440129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation.
    Buteau J; Foisy S; Rhodes CJ; Carpenter L; Biden TJ; Prentki M
    Diabetes; 2001 Oct; 50(10):2237-43. PubMed ID: 11574404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
    Perfetti R; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells.
    Trümper J; Ross D; Jahr H; Brendel MD; Göke R; Hörsch D
    Diabetologia; 2005 Aug; 48(8):1534-40. PubMed ID: 15995848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells.
    Wang Q; Li L; Xu E; Wong V; Rhodes C; Brubaker PL
    Diabetologia; 2004 Mar; 47(3):478-487. PubMed ID: 14762654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle.
    Acitores A; González N; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
    J Endocrinol; 2004 Mar; 180(3):389-98. PubMed ID: 15012593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor.
    Buteau J; Foisy S; Joly E; Prentki M
    Diabetes; 2003 Jan; 52(1):124-32. PubMed ID: 12502502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells.
    Susini S; Roche E; Prentki M; Schlegel W
    FASEB J; 1998 Sep; 12(12):1173-82. PubMed ID: 9737720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
    Lawrence MC; Bhatt HS; Easom RA
    Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
    Chepurny OG; Holz GG
    Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity.
    Buteau J; El-Assaad W; Rhodes CJ; Rosenberg L; Joly E; Prentki M
    Diabetologia; 2004 May; 47(5):806-15. PubMed ID: 15095038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
    Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
    Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.
    Zhao AZ; Bornfeldt KE; Beavo JA
    J Clin Invest; 1998 Sep; 102(5):869-73. PubMed ID: 9727054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2.
    Rafiq I; da Silva Xavier G; Hooper S; Rutter GA
    J Biol Chem; 2000 May; 275(21):15977-84. PubMed ID: 10821851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
    Hui H; Nourparvar A; Zhao X; Perfetti R
    Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin stimulates pancreatic-duodenal homoeobox factor-1 (PDX1) DNA-binding activity and insulin promoter activity in pancreatic beta cells.
    Wu H; MacFarlane WM; Tadayyon M; Arch JR; James RF; Docherty K
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):813-8. PubMed ID: 10585868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells.
    Wang X; Cahill CM; Piñeyro MA; Zhou J; Doyle ME; Egan JM
    Endocrinology; 1999 Oct; 140(10):4904-7. PubMed ID: 10499550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.